» Articles » PMID: 19362679

Tim-3-Galectin-9 Pathway Involves the Suppression Induced by CD4+CD25+ Regulatory T Cells

Overview
Journal Immunobiology
Publisher Elsevier
Date 2009 Apr 14
PMID 19362679
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

CD4(+)CD25(+) regulatory T cells (Tregs) are considered to play a key role as suppressors of immune-mediated reactions. The mechanisms of this suppression in animals and patients with autoimmune, allergic or oncogenic diseases have been investigated under various conditions. However, the precise mode of suppression by CD4(+)CD25(+) Tregs is still not clear. In this report, Tim-3-Galectin-9 pathway was explored as one of the mechanisms for the suppression and cytotoxicity induced by Tregs. Here, we demonstrated that Galectin-9 was expressed on CD4(+)CD25(+) Tregs by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. Interestingly, blocking Tim-3-Galectin-9 pathway resulted in an obvious decreased suppression activity of Tregs and enhanced Th1 cytokine level in vitro. Furthermore, blocking Tim-3-Galectin-9 pathway negated prolonged survival of allogeneic skin grafts induced by CD4(+)CD25(+) Tregs in vivo. Our results suggest that Tim-3-Galectin-9 pathway involves the function of CD4(+)CD25(+) Tregs.

Citing Articles

Immunotherapeutic Approaches for the Treatment of Glioblastoma Multiforme: Mechanism and Clinical Applications.

Das S, Dash B, Premji T, Chen J Int J Mol Sci. 2023; 24(13).

PMID: 37445721 PMC: 10341481. DOI: 10.3390/ijms241310546.


Inhibition of galectins in cancer: Biological challenges for their clinical application.

Laderach D, Compagno D Front Immunol. 2023; 13:1104625.

PMID: 36703969 PMC: 9872792. DOI: 10.3389/fimmu.2022.1104625.


Exploration of the Crucial Genes and Molecular Mechanisms Mediating Atherosclerosis and Abnormal Endothelial Shear Stress.

Zhu G, Lai Y, Chen F, Qian J, Lin H, Yuan D Dis Markers. 2022; 2022:6306845.

PMID: 35990248 PMC: 9391161. DOI: 10.1155/2022/6306845.


A roadmap for translational cancer glycoimmunology at single cell resolution.

Peixoto A, Miranda A, Santos L, Ferreira J J Exp Clin Cancer Res. 2022; 41(1):143.

PMID: 35428302 PMC: 9013178. DOI: 10.1186/s13046-022-02335-z.


Medawar's PostEra: Galectins Emerged as Key Players During Fetal-Maternal Glycoimmune Adaptation.

Menkhorst E, Than N, Jeschke U, Barrientos G, Szereday L, Dveksler G Front Immunol. 2022; 12:784473.

PMID: 34975875 PMC: 8715898. DOI: 10.3389/fimmu.2021.784473.